ing for SP-B has been located and a frameshift mutation in this gene has been identified in the reported sibship and in two other families.2 A further six cases of SP-B deficiency with varying clinical and genetic findings have been described.3 We describe the first British cases in two siblings.
Case 1 This first girl of healthy, non-consanguineous, caucasian parents was born in 1991, at termn, weighing 3-5 kg. Apgar scores were nine and 10 at one and five minutes, respectively. At 5 hours of age she developed respiratory distress and was mechanically ventilated. She 
Comment
These tWO infants illustrate the clinical presentation of this newly diagnosable condition. The histological findings are identical with those seen in pulmonary alveolar proteinosis, a rare alveolar disease described in older children and adults. The aetiology of this condition is unknown but in babies presenting from birth it is likely to be due to surfactant B protein deficiency. This diagnosis should be considered in all term babies dying of respiratory distress. As further mutations are identified antenatal diagnosis will be possible and in the future gene therapy may be effective. We have subsequently identified two further cases in Asian babies. We urgently need data on the prevalence of this condition in Britain and we have contacted the British Paediatric Surveillance Unit with a view to establishing this. We have attempted to synchronise both phases of respiration using VIP Bird Infant Ventilators. These systems can utilise proximal endotracheal tube flow as a sensitive signal to cycle into inspiration. However, infants display a wide variation in spontaneous respiratory rate related to the level of arousal. When the infant triggers ventilator breaths with preset inspiratory times during periods of high respiratory rate, there is a danger of 'reversed ratios', and the inspiratory time exceeds the expiratory time (Te). Moreover, using a graphical interface, which displays breath to breath measurements of endotracheal flow and pressure and volume in real time, we have also demonstrated that endotracheal inspiratory flow may decay to zero or to minimum flow (generated by continuous gas leak around the tube) well before the elapse of a preset inspiratory time. Thus alveolar ventilation does not occur throughout the fixed inspiratory cycle.
In weaning babies not dependent on a high mean airways pressure for oxygenation, fixed inspiratory time can be reduced without adverse effects on blood gases. On the VIP Bird ventilator there is an algorithm to reduce the delivered inspiratory time during fast breathing and increase it during slower breathing, known as 'termination sensitivity'. This uses the detection of inspiratory flow decay to signal termination of ventilator inspiration. Thus ventilation becomes pressure limited, and flow cycled into both inspiration and expiration, allowing the infant to select its own inspiratory time. We use the 'termination sensitivity', to modulate the delivered inspiratory time in weaning infants to 0-2 to 0-25 seconds. We have confirmed previously reported observed improvements in patient blood gases and comfort.3 Inspiratory flow decay is subject to lung volume and time constant, and may be confounded by altered peak ventilator pressure and changes in pulmonary dynamics.
The use of the graphical display of pressure-volume loops in real time allows us to optimise ventilator pressure to minimise these effects. In addition, as with all ventilator settings, termination sensitivity is subject to rigorous review and adjustment on a frequent basis, which minimises variation induced by the compliance of changing lung pathology.
The Graseby capsule used in the method described' has been shown to be less effective as a sensor for inspiration synchronised ventilator systems, because of difficulties with placement ofthe transducer and a long trigger delay time. 
